American Healthcare REIT (AHR) Cost of Revenue (2017 - 2026)

American Healthcare REIT has reported Cost of Revenue for 10 years, with the latest figure at $512.2 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 18.44% year-over-year to $512.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.9 billion (up 11.33% YoY), and the FY2025 full-year result was $1.8 billion, up 8.44% from the prior year.
• Cost of Revenue for Q1 2026 stood at $512.2 million, up from $480.3 million in the prior quarter.
• The five-year high for Cost of Revenue was $512.2 million in Q1 2026, with the low at $287.2 million in Q1 2022.
• Historically, Cost of Revenue has averaged $396.7 million across 5 years, with a median of $402.6 million in 2024.
• Annual changes were most pronounced in 2022 — Cost of Revenue soared 31.41% — and 2025, when it gained 5.89%.
• American Healthcare REIT's Cost of Revenue stood at $360.8 million in 2022, then advanced by 6.7% to $385.0 million in 2023, then increased by 11.83% to $430.6 million in 2024, then grew by 11.55% to $480.3 million in 2025, then advanced by 6.64% to $512.2 million in 2026.
• The last three Cost of Revenue figures came in at $512.2 million (Q1 2026), $480.3 million (Q4 2025), and $454.5 million (Q3 2025), per Business Quant data.